Abstract | PURPOSE: MATERIALS AND METHODS: RESULTS: According to strict inclusion criteria, database searches identified 8 placebo-controlled studies that included 2284 patients. Generally, α-blockers had no significant effect on the clearance of stones in the urinary tract (risk ratio [RR] = 1.05; 95% confidence interval [CI] = 1.00-1.11). However, subgroup analysis showed that α-blockers were effective in treating distal urinary tract stones (RR = 1.08; 95% CI = 1.02-1.15). With regards to adverse events, our analysis showed that the combination of MET with α-blockers was likely to cause dizziness (RR = 1.37; 95% CI = 1.06-1.79) and retrograde ejaculation (RR = 3.10; 95% CI = 1.81-5.29). CONCLUSION: Although α-blockers cannot improve the overall ureteral stone clearance rate, these drugs are still effective for the treatment of stones in the distal urinary tract. However, the application of α-blockers is likely to cause dizziness and/or retrograde ejaculation.
|
Authors | Ze-Wei Yu, Rui-Hong Wang, Chang-Cun Zhang, Jian-Gang Gao |
Journal | Medicine
(Medicine (Baltimore))
Vol. 100
Issue 37
Pg. e27272
(Sep 17 2021)
ISSN: 1536-5964 [Electronic] United States |
PMID | 34664882
(Publication Type: Journal Article, Meta-Analysis, Systematic Review)
|
Copyright | Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. |
Chemical References |
- Adrenergic alpha-Antagonists
- Placebos
|
Topics |
- Adrenergic alpha-Antagonists
(pharmacology, therapeutic use)
- Humans
- Odds Ratio
- Placebos
- Treatment Outcome
- Ureteral Calculi
(drug therapy)
|